EGFR and non-small cell lung carcinoma: This system has been used successfully for the detection of KRAS, EGFR, and/or BRAF mutations on routine FFPE tissue of colorectal carcinoma, melanoma, lung cancer, thyroid cancer, and breast cancer [7–11] and stained cytological NSCLC smears [12].